DiTommaso v. Medicines Co.

754 F. Supp. 2d 702, 2010 U.S. Dist. LEXIS 129395, 2010 WL 4977034
CourtDistrict Court, D. New Jersey
DecidedDecember 7, 2010
DocketCivil Action 10-1868 (JEI/KMW)
StatusPublished
Cited by4 cases

This text of 754 F. Supp. 2d 702 (DiTommaso v. Medicines Co.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DiTommaso v. Medicines Co., 754 F. Supp. 2d 702, 2010 U.S. Dist. LEXIS 129395, 2010 WL 4977034 (D.N.J. 2010).

Opinion

OPINION

IRENAS, Senior District Judge:

This matter appears before the Court on Defendant’s Motion to Dismiss the Complaint, pursuant to Federal Rule of Civil Procedure 12(b)(6). 1 For the reasons sets forth below, the Court will grant in part and deny in part the Motion.

I.

The following facts are alleged in the Complaint. Defendant, The Medicines Company, (“Medco”) employed Plaintiff, Monica DiTommaso, (“DiTommaso”) as a salesperson from February 6, 2002, until on or about April 7, 2009. (Complaint ¶¶ 9-10) DiTommaso is a “Caucasian individual.” (Id. at 9). During her employment, DiTommaso consistently achieved a high percentage of her sales goals, exceeding the minimum level of achievement required to receive sales commissions from Medco. (Id. at 11)

In 2006 and 2007, Reginald Davis (“Davis”), DiTommaso’s manager and an “African-American individual”, failed to increase DiTommaso’s salary based on her race. Davis did provide salary increases to African-American employees, each of whom had lower sales figures than DiTommaso. (Id. at 13) DiTommaso registered a complaint of racial discrimination with Medco’s human resources director, but no corrective action was taken. (Id. at 14)

In retaliation for DiTommaso’s complaints, Davis reassigned several of DiTommaso’s most profitable accounts to other, less qualified employees. (Id. at 15) Davis allowed similarly situated African-American employees to choose their assigned accounts. (Id. at 17) DiTommaso was also denied the opportunity to attend an industry conference, while certain African-American employees with less tenure than DiTommaso were allowed to attend. (Id. at 16) In further retaliation, Davis refused to intervene on behalf of DiTommaso with a customer who was making sexually-offensive comments, and refused to adjust working hours for DiTommaso while allowing such adjustments for similarly situated Africa-American employees. (Id. at 19) Davis also refused to reduce DiTommaso’s sales quota without proper documentation from a customer, while lowering sales quotas of similarly situated Africa-American employees without such documentation. (Id. at 20)

Again, DiTommaso registered a complaint of racial discrimination, this time with Medco’s area sales director, but no corrective action was taken. (Id. at 21). Further retaliation continued. In March 2009, Davis issued DiTommaso a negative review for failing to meet her sales quota, even though such failure was the result of Davis’s racial discrimination and retaliatory acts. (Id. at 22) Davis did not issue negative reviews to similarly situated Africa-American employees, even if those employees that failed to meet their sales quotas. (Id.)

Medco terminated DiTommaso on April 7, 2009, due to poor sales performance. (Id. at 23) Medco did not terminate similarly situated Africa-American employees with sales performances inferior to DiTommaso. (Id. at 24)

DiTommaso filed her original complaint on April 13, 2010. Medco then filed this Motion to Dismiss under Rule 12(b)(6) on June 22, 2010. 2

*704 Count I of the Complaint alleges that Medco discriminated against DiTommaso because of her race in violation of 42 U.S.C. § 1981. Count II of the Complaint alleges that Medco retaliated against DiTommaso for her opposition to race discrimination in the workplace in violation of § 1981. Count III of the Complaint alleges that Medco discriminated against DiTommaso in violation of the New Jersey Law Against Discrimination (“LAD”), N.J.S.A. 10:5-1 et. seq. Count IV of the Complaint alleges that Medco retaliated against DiTommaso in violation of the LAD.

For the reasons explained herein, the Court will deny Defendant’s Motion to Dismiss as to Counts I and II, and will grant the Motion as to Counts III and IV. 3

II.

Federal Rule of Civil Procedure 12(b)(6) provides that a court may dismiss a complaint “for failure to state a claim upon which relief can be granted.” In order to survive a motion to dismiss under Federal Rule of Civil Procedure 12(b)(6), a complaint must allege facts that raise a right to relief above the speculative level. Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 127 S.Ct. 1955, 1965, 167 L.Ed.2d 929 (2007); see also Fed.R.Civ.P. 8(a)(2). While a court must accept as true all allegations in the plaintiffs complaint, and view them in the light most favorable to the plaintiff, Phillips v. County of Allegheny, 515 F.3d 224, 231 (3d Cir.2008), a court is not required to accept sweeping legal conclusions cast in the form of factual allegations, unwarranted inferences, or unsupported conclusions. Morse v. Lower Merion Sch. Dist., 132 F.3d 902, 906 (3d Cir.1997). The complaint must state sufficient facts to show that the legal allegations are not simply possible, but plausible. Phillips, 515 F.3d at 234.

III.

DiTommaso’s claims under § 1981 are governed by the burden-shifting principles set forth by the Supreme Court:

First, the plaintiff has the burden of proving by the preponderance of the evidence a prima facie case of discrimination. Second, if the plaintiff succeeds in proving the prima facie case, the burden shifts to the defendant “to articulate some legitimate, nondiscriminatory reason for the employee’s rejection.” Third, should the defendant carry this burden, the plaintiff must then have an opportunity to prove by a preponderance of the evidence that the legitimate reasons offered by the defendant were not its true reasons, but were a pretext for discrimination.

Texas Dep’t of Cmty. Affairs v. Burdine, 450 U.S. 248, 252-53, 101 S.Ct. 1089, 67 L.Ed.2d 207 (1981) (citations omitted)(quoting McDonnell Douglas Corp. v. Green, 411 U.S. 792, 802, 93 S.Ct. 1817, 36 L.Ed.2d 668 (1973)). 4

*705 A.

The Third Circuit has adopted a modified

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
754 F. Supp. 2d 702, 2010 U.S. Dist. LEXIS 129395, 2010 WL 4977034, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ditommaso-v-medicines-co-njd-2010.